Originally Posted by
acidfast7
Actually, they're not profitable (not even close) and no they're not being actively developed as they result in huge losses as they're not used in chronic patients (10-14 days max on a €1-5B investment leads to crappy fiscal returns.) Over here, the only viable solution being discussed is nationalised screening and production.
FWIW, this is my current major research avenue.
Is it true that governments (such as mine) also put price caps on antibiotics, so there's even less motive to develop them? That's what I heard somewhere.